Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes.

Viktor Rotbain CurovicBrede A SørlandTine W HansenSiddhi Y JainKarolina SulekIsmo Matias MattilaMarie Frimodt-MøllerKajetan TrostCristina Legido-QuigleySimone TheiladeNete TofteSigne Abitz WintherChristian Stevns HansenEllen Burgess Tarunveer Singh Ahluwalia

Published in: BMJ open diabetes research & care (2024)

While prospective studies directly assessing the predictive ability of these markers are needed, our results strengthen the role of clinical metabolomics in relation to risk assessment of diabetic complications in chronic type 1 diabetes.

Keyphrases

type diabetes
risk assessment
risk factors
glycemic control
cardiovascular disease
insulin resistance
mass spectrometry
wound healing
skeletal muscle
climate change
drug induced